Rita King, CEO of MethodSense, provides her expertise on the integration of AI in medical devices and key developments for pharmacists as the technology evolves.
|Expert Interviews|December 31, 2020
Year in Review and 2021 Pharmacy Trends: COVID-19 Impacts, PBM Accountability
Stephen Schondelmeyer, PharmD, Drug Topics editorial advisory board member, discusses pharmacy highlights from 2020, and where he sees pharmacy headed in 2021.
Advertisement
Advertisement
Related to this article
Investigators link oversight with eroding trust in health authorities and call on future pandemic inquiries to weigh trade-offs.
Harini Bupathi, Esq, joins to discuss the impacts of PBM network terminations and how pharmacies can recover financially.
Pharmacists expand access with no-appointment care but face state laws limiting test-to-treat for COVID-19 and flu, fueling calls for advocacy.
Cheri Schmit explains how pharmacists' roles are growing beyond dispensing into prevention, test-and-treat, and artificial intelligence-supported patient care.
In celebration of American Pharmacists Month, Melissa McGivney, PharmD, FAPhA, FCCP, provides a snapshot of where the profession has come and where it still has to go.
Melissa McGivney, PharmD, FAPhA, FCCP, helps celebrate American Pharmacists Month and the innovation driving the profession forward amongst US communities.
Melissa McGivney, PharmD, FAPhA, FCCP, discusses her career journey from her local pharmacy to a national leadership role with the American Pharmacists Association.
Advertisement
Advertisement
Trending on Drug Topics
1
PBM Underpayment Persists as Cost-Plus Brings New Strain | NCPA 2026
2
Q&A: Why Enforcement Is the Weak Link in State PBM Reform | NCPA 2026
3
Pharmacist Roles, Risks in Guiding AI-Enabled Medical Device Use
4
Vaccine Fatigue May Stall Patient Uptake More Than Hesitancy
5